24/10/2026
🎉 Congratulations on WeeNaso™ Nasal Hemostatisis Dressing/splint accquiring U.S. FDA Market Authorization!
Designed to provide temporary compression for hemostasis and support following nasal surgery, WeeNaso™ gradually dissolve within one week after use, with the resulting fragments naturally cleared from the nasal cavity. By combining biodissolvable biomaterials with a patient-centered approach to postoperative care, this innovation reflects the continued progress of ENT technology toward improved patient comfort and simplified clinical workflows.
👏 Congratulations to the entire team on this achievement! We look forward to seeing more innovative medical technologies from WeSeal Medical reach international markets and contribute to better patient care worldwide.